Literature DB >> 11371048

Electrochemical behaviour of sertraline at a hanging mercury drop electrode and its determination in pharmaceutical products.

M H Vela1, M B Quinaz Garcia, M C Montenegro.   

Abstract

The electrochemical behaviour of sertraline at a hanging mercury drop electrode (HMDE) was described. Different voltammetric techniques, such as cyclic, linear sweep, differential pulse and square wave voltammetry, were used. Voltammograms were obtained at different pH values with a Britton-Robinson buffer solution used as supporting electrolyte. The best results were found by square wave voltammetry with electrodeposition at alkaline pH using a borate buffer with a pH = 8.2 for the samples, containing 12% (v/v) methanol. Under optimised conditions, a linear relationship between 2.33 x 10(-7) and 3.15 x 10(-6) M of sertraline with a limit of detection of 1.98 x 10(-7) M was obtained. The electrochemical method developed was applied to the determination of sertraline in pharmaceutical formulations. Recoveries were close to 100%, thus proving efficacy of the proposed method for the quantification of sertraline in commercial samples.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11371048     DOI: 10.1007/s002160000686

Source DB:  PubMed          Journal:  Fresenius J Anal Chem        ISSN: 0937-0633


  3 in total

1.  Spectroscopic and electrochemical analysis of psychotropic drugs.

Authors:  H Puzanowska-Tarasiewicz; W Misiuk; K Mielech-Łukasiewicz; L Kuźmicka
Journal:  Indian J Pharm Sci       Date:  2009-01       Impact factor: 0.975

2.  Spectrofluorimetric determination of sertraline in dosage forms and human plasma through derivatization with 9-fluorenylmethyl chloroformate.

Authors:  Nahed M El-Enany; Amina Abdelal; Fathalla Belal
Journal:  Chem Cent J       Date:  2011-10-06       Impact factor: 4.215

3.  Artificial Neural Networks (ANN) for the Simultaneous Spectrophotometric Determination of Fluoxetine and Sertraline in Pharmaceutical Formulations and Biological Fluid.

Authors:  Hamid Reza Akbari Hasanjani; Mahmoud Reza Sohrabi
Journal:  Iran J Pharm Res       Date:  2017       Impact factor: 1.696

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.